Alignment Healthcare, Inc.
ALHC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -3.05 | -0.17 | 1.40 | -1.22 |
| FCF Yield | 4.63% | 0.76% | 0.23% | -0.83% |
| EV / EBITDA | 203.28 | 88.27 | 1,554.49 | -109.57 |
| Quality | ||||
| ROIC | 1.56% | 4.01% | -1.23% | -5.23% |
| Gross Margin | 12.65% | 13.15% | 11.44% | 12.31% |
| Cash Conversion Ratio | 38.77 | 1.86 | -1.78 | 0.28 |
| Growth | ||||
| Revenue 3-Year CAGR | 28.35% | 27.13% | 25.25% | 23.53% |
| Free Cash Flow Growth | 661.16% | 152.59% | 146.48% | -206.42% |
| Safety | ||||
| Net Debt / EBITDA | -18.41 | -4.71 | -52.00 | 5.52 |
| Interest Coverage | 1.94 | 5.76 | -1.37 | -4.11 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -22.26 | -11.80 | -13.06 | -15.74 |